Trump administration reschedules marijuana

In a historic policy reversal, the Department of Justice has signed an order reclassifying state-approved medical marijuana as a less dangerous substance.

While the move does not fully legalize the drug at the federal level, it acknowledges potential medical benefits and lowers the regulatory hurdles for scientific study.

The shift is expected to provide a massive financial boost to the cannabis industry by allowing firms to claim standard business tax deductions.

However, the decision has drawn sharp criticism from some conservative lawmakers who argue it sends a dangerous message about drug safety.